- Report
- December 2024
- 150 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- July 2025
- 150 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 197 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£954GBP
- Report
- December 2024
- 84 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- September 2025
- 281 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 364 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Report
- August 2025
- 189 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 183 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- January 2025
- 200 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- November 2018
- 147 Pages
Global
From €2425EUR$2,750USD£2,100GBP
- Report
- February 2024
- 168 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Report
- July 2023
- 135 Pages
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- July 2023
- 67 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- October 2023
- 145 Pages
Global
From €2778EUR$3,150USD£2,405GBP
- Report
- October 2023
- 145 Pages
Global
From €2778EUR$3,150USD£2,405GBP
- Report
- May 2024
- 139 Pages
Global
From €5732EUR$6,499USD£4,962GBP

Opioid Use Disorder (OUD) is a type of addiction disorder that is characterized by the compulsive use of opioids, such as heroin, morphine, and prescription painkillers. OUD is a serious public health issue, with an estimated 2.1 million people in the United States suffering from the disorder. OUD is associated with a range of physical and psychological health problems, including an increased risk of overdose, infectious diseases, and mental health issues. Treatment for OUD typically involves a combination of medication-assisted treatment (MAT) and psychosocial interventions. MAT involves the use of medications, such as buprenorphine and methadone, to reduce cravings and withdrawal symptoms. Psychosocial interventions include cognitive-behavioral therapy, motivational interviewing, and 12-step programs.
Companies in the OUD market include Indivior, Alkermes, Orexo, and Braeburn Pharmaceuticals. Show Less Read more